tirzepatide while breastfeeding 🚨 New Research Alert: & — What You Should Know! 🍼 There's a lot of buzz right now about tirzepatide and breastfeeding — and for good reason. 🍼✨ Many postpartum tirzepatide breastfeeding guidance Is Tirzepatide

International Regulatory Landscape Healthcare Provider Considerations Healthcare providers who prescribe or recommend BPC-157 face potential: Disciplinary action from state medical boards Medical license implications (sanctions, restrictions, suspension) Malpractice liability (insurance often excludes experimental treatments) Federal regulatory enforcement Research and Access Legitimate research pathways: Investigational New Drug (IND) application required for human research Institutional Review Board (IRB) approval required GMP standards required for research-grade materials Current access: Research peptide suppliers (variable quality) Some compounding pharmacies (legal status varies) Clinical trials (limited availability) Why This Regulatory Status Exists BPC-157's prohibition stems from: Limited clinical data Only small pilot studies published (~28 human subjects total)

51 Ece Bayram, and Irene Litvan

This process explains why copper peptides are so effective at helping wounds heal and reducing scar formation

Believe it or not, we produce over 200,000 different peptides

Tirzepatide is defined as a dual GIP/GLP-1 receptor agonist prescribed for type 2 diabetes management and chronic weight management in adults